La vendita allo scoperto per NewGenIvf Group dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di NewGenIvf Group. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

NewGenIvf Group (NASDAQ:NIVF) Azioni, Report sulle vendite allo scoperto

NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.

NewGenIvf Group Limited - Class A Ordinary Shares

NewGenIvf Group Ltd

Wells Fargo analyst Jared Shaw maintains Bank OZK (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OZK#NASDAQ">OZK</a>) with a Equal-Weight and lowers the price target from $48 to $40.

News

Price Target

Analyst Ratings

Wells Fargo Maintains Equal-Weight on Bank OZK, Lowers Price Target to $40

Wells Fargo analyst Timur Braziler maintains Banc of California (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BANC#NYSE">BANC</a>) with a Overweight and lowers the price target from $20 to $16.

BANC

Wells Fargo Maintains Overweight on Banc of California, Lowers Price Target to $16

<figure class="wp-block-image size-large"><img decoding="async" src="https://thearorareport.com/wp-content/uploads/2025/04/2025-04-09_08h58_59.png" alt="" /></figure>
To gain an edge, this is what you need to know today.
<h4 class="wp-block-heading">Look Ahead</h4>
Please <a href="https://thearorareport.com/stock-market-chart-bond-canary-in-coal-mine-china-tariffs-spy-mc-04092025">click here</a> for an enlarged chart of SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) which represents the benchmark stock market index S&amp;P 500 (SPX).
Note the following:
<ul>
<li>The chart, along with this article, illustrates the power of looking ahead.  As important as it is to look ahead, it is equally important to learn what not to do.  The chart illustrates a powerful example of what not to do.  The chart shows the momo crowd fell into the trap of not looking ahead.
<ul>
<li>The chart shows that the momo crowd was buying Friday morning because the momo crowd believed that the stock market bottom was in place after the selloff on Thursday.</li>
<li>The chart shows a major drop on Friday after the momo crowd aggressively bought.   The drop caused the momo crowd to panic and sell near the lows.</li>
<li>Later on Friday and over the weekend, proclamations from momo gurus that Monday would see a crash like 1987 spread like wildfire.  As a reference, in 1987, the stock market fell over 20% in one day.</li>
<li>The chart shows the momo crowd panicked on Monday morning and sold at the lows.</li>
<li>The chart shows that the stock market rallied on Monday after the momo crowd sold.</li>
<li>On Tuesday morning, the momo crowd discovered that negotiations were ahead.  In our <a href="https://www.benzinga.com/markets/equities/25/04/44669616/protection-band-is-the-answer-for-investors-wall-street-abandons-trump-but-trump-appears-resolut">Monday's </a>Morning Capsule.  We wrote: </li>
<li>"In the middle of all of this gloom, we would like to point out green shoots.</li>
<li>President Trump had a very positive call with the Secretary of the Communist Party of Vietnam.  Vietnam is indicating zero tariffs on U.S. goods.</li>
<li>Taiwan is choosing not to retaliate but instead to work with President Trump.</li>
<li>India is choosing not to retaliate and instead focus on a bilateral trade deal with the U.S.</li>
<li>Cambodia is choosing not to retaliate and is actively seeking to negotiate with the U.S.</li>
<li>Mexico is taking a measured approach and does not intend to engage in tit-for-tat tariffs.</li>
<li>The U.K. is taking a measured approach.</li>
<li>Elon Musk is floating the idea of a zero tariff trade zone between Europe and the U.S."</li>
</ul>
</li>
<li>On Tuesday morning, the momo crowd bought aggressively.  The momo crowd forgot that 50% additional tariffs on China were ahead.  Tuesday morning, when the stock market was running up like crazy, we wrote: &#8220;In the middle of the euphoria that has broken out this morning, Wall Street is not thinking ahead.&#8221;</li>
</ul>

<ul>
<li>How will the stock market react if Trump goes ahead and imposes 50% additional tariffs on China?"
<ul>
<li>The chart shows when the stock market started realizing that additional China tariffs were ahead.</li>
<li>The chart shows that after the stock market realized China tariffs were ahead, the stock market fell.  The chart shows that the stock market drop picked up steam after the White House confirmed new China tariffs.</li>
<li>After buying near the highs in the morning, the momo crowd again panicked and sold near the lows yesterday.</li>
<li>The chart shows that early this morning, the momo crowd was buying again because China had not responded to the additional tariffs.</li>
<li>The chart shows that the stock market started falling again when China retaliated with 84% tariffs on U.S. goods.</li>
</ul>
</li>
<li>The foregoing illustrates the foolishness of not looking ahead and buying when the market goes up, only to sell when the market goes down.</li>
<li>In our analysis, prudent investors need to understand the following:
<ul>
<li>To stay in control in China, for domestic reasons, President Xi cannot appear to have bowed to President Trump.</li>
<li>The U.S. strategy is to isolate China.  If the U.S. is successful in isolating China, China will have no choice but to give into President Trump.</li>
<li>China's strategy is to isolate the U.S.  If China is successful, President Trump will have no choice but to give into China.</li>
<li>It is a game of chess.  In our analysis, if President Trump is able to hold his nerve, the U.S. will be the likely winner.  If President Trump loses his nerve, China will be the likely winner.  </li>
</ul>
</li>
<li>The U.S. has an advantage for three reasons:
<ul>
<li>The U.S. is a trade deficit nation.  In a trade war, a trade deficit nation always has an advantage.</li>
<li>The U.S. consumer is very powerful compared to the Chinese consumer.</li>
<li>The U.S. has more allies than China.</li>
</ul>
</li>
<li>In our analysis, the U.S. is in a very good position with 70 countries, other than China, and is likely to come out way ahead compared to the present state of other nations continuously taking wealth out of the U.S. </li>
<li>For investors to fully understand what is happening and how it might end, investors may refer to the change curve that Nigam Arora described in his book titled "Theory ZYX of Successful Change Management: A Definitive Guide to Reach the Next Level." Nigam wrote in his book that when a major change is envisioned, those who have benefited from the status quo rise up with hue and cry.  The reason for hue and cry is that the change is like taking candy away from a baby.  On the flip side, since the change has not yet occurred, no one has benefited from the change.  There you have it – on one side you have a large segment of the population that will lose from the change, and on the other side, no one has yet benefited from the change.</li>
<li>In our analysis, most major U.S. corporations and about 20% of the U.S. population have become significantly wealthier by the hollowing out of America.  These beneficiaries will be the losers from President Trump's policies.  The problem with the stock market is the 20% who have benefited are the ones who own stocks outside of retirement accounts.  On the flip side, about 50% of the U.S. population that has lost out from the hollowing out of America does not own stocks.</li>
<li>In our analysis, if President Trump can hold his nerve, in the long run the change will be good for stock market investors.  As we have written before, the problem is the chasm in the short term.  Having said that, prudent investors should not ignore the risk in the long term if one of the following occurs:
<ul>
<li>President Trump loses his nerve.</li>
<li>President Trump loses public support in the U.S.</li>
<li>Instead of the U.S. succeeding in isolating China, China succeeds at isolating the U.S.</li>
</ul>
</li>
<li>Looking ahead, consider the following:
<ul>
<li>Follow one of the tenets of The Arora Report method to always be booking some profits.  From the Trade Management Guidelines: "The concept is to take partial profits to reduce risk and let the remaining position run for the profits to grow. The judicious combination of the two leads to maximizing risk adjusted returns over a long period of time over a large number of trades."</li>
<li>Since Trump's re-election, we have given 235 profit taking signals.  This is an example of practical actions in accordance with the principle explained above.  Investors who took advantage of the 235 profit taking signals now have some cushion as long term positions suffer.  </li>
<li>Following the protection band.</li>
<li>A judicious combination of long term strategic positions, short term tactical positions, cash, gold, and hedges. </li>
</ul>
</li>
<li>In yesterday's Morning Capsule, we wrote:</li>
</ul>
"In our analysis, prudent investors should pay attention to bonds.  At this point in time, bonds are like a canary in the coal mine.  Bond yields have rapidly risen from their lows yesterday morning in a dizzying move.  Yields on 10 year Treasuries have risen from 3.865% yesterday morning to 4.226% as of this writing."
<ul>
<li>The result of the $58B three year note auction showed weak demand.  This indicates that the canary is sick.  Here are the details of the auction:
<ul>
<li>High yield: 3.908%</li>
<li>Bid-to-cover: 2.70</li>
<li>Indirect bid: 62.5%</li>
<li>Direct bid: 26.0%</li>
</ul>
</li>
<li>At this time, consider paying attention to the protection band and paying attention to new signals.  For example, partial profits were taken on the Nvidia (NVDA) trade around position at $103.86 and $105.33 yesterday.  Earlier this morning, NVDA stock traded as low as $93.25.  The core NVDA position that is long from $12.55 has hedges.  These hedges have become very profitable.  Recently, partial profits were taken on the hedges.</li>
<li>As of this writing, the dollar is experiencing a big drop.  The stock market is liking it, but this should be of concern to investors.  </li>
<li>Important economic data is ahead. Consumer Price Index (CPI) and initial jobless claims will be released tomorrow at 8:30am ET.  Producer Price Index (PPI) will be released Friday at 8:30am ET.</li>
<li>As an actionable item, the sum total of the foregoing is in the protection band, which strikes the optimum balance between various crosscurrents.   Please scroll down to see the protection band. </li>
</ul>
<h4 class="wp-block-heading">Magnificent Seven Money Flows</h4>
In the early trade, money flows are like a yoyo in Apple Inc (AAPL), Amazon.com, Inc. (AMZN), Alphabet Inc Class C (GOOG), Meta Platforms Inc (META), Microsoft Corp (MSFT), (NVDA), and Tesla Inc (TSLA).
In the early trade, money flows are like a yoyo in S&amp;P 500 ETF (SPY) and Invesco QQQ Trust Series 1 (QQQ).
The foregoing indicates a high degree of instability this morning.
<h4 class="wp-block-heading">Momo Crowd And Smart Money In Stocks</h4>
Investors can gain an edge by knowing money flows in SPY and QQQ.  Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.  The most popular ETF for gold is SPDR Gold Trust (GLD).  The most popular ETF for silver is iShares Silver Trust (SLV).  The most popular ETF for oil is United States Oil ETF (USO).
<h4 class="wp-block-heading">Bitcoin</h4>
Bitcoin is seeing selling.
<h4 class="wp-block-heading">Protection Band And What To Do Now</h4>
It is important for investors to look ahead and not in the rearview mirror.  Our proprietary protection band puts all of the data, all of the indicators, all of the news, all of the crosscurrents, all of the models, and all of the analysis in an analytical framework that is easily actionable by investors.
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp; The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp; If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp; A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp; When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp; High beta stocks are the ones that move more than the market.
<h4 class="wp-block-heading">Traditional 60/40 Portfolio</h4>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.&nbsp; Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.
The Arora Report is known for its accurate calls. The Arora Report correctly called the big artificial intelligence rally before anyone else, the new bull market of 2023, the bear market of 2022, new stock market highs right after the virus low in 2020, the virus drop in 2020, the DJIA rally to 30,000 when it was trading at 16,000, the start of a mega bull market in 2009, and the financial crash of 2008. Please click here to sign up for a free forever <a href="https://thearorareport.com/generate-wealth-newsletter-benzinga">Generate Wealth Newsletter</a>.

Equities

Market Summary

Opinion

Markets

ETFs

Here Is How To Look Ahead In This Market, China Dashes Stock Market Bulls Hopium, Bond Canary Sick

Wells Fargo analyst Deepa Raghavan maintains Lennar (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) with a Equal-Weight and lowers the price target from $120 to $110.

Wells Fargo Maintains Equal-Weight on Lennar, Lowers Price Target to $110

WIIM

ADBE

ADSK

APPN

ASAN

BILL

DDOG

SOUN

Shares of software companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

YieldMax has introduced a new product to its expanding lineup of <a href="https://www.benzinga.com/etfs">income-producing ETFs</a>, but this time it&#8217;s aimed at the semiconductor industry. 
What Happened: The YieldMax Semiconductor Portfolio Option Income ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHPY#NYSE">CHPY</a>), shares exposure to stocks in the chip industry with a variety of options strategies to produce regular income. The fund is priced at an expense ratio of 0.99%.
CHPY is actively managed and maintains a portfolio of 15 to 30 U.S.-listed semiconductor stocks, such as widely recognized names as NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), and Qualcomm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>). The fund also attempts to profit from market volatility by executing options trades in the form of covered calls, put-selling, credit spreads, and collars. The <a href="https://www.globenewswire.com/news-release/2025/04/03/3054965/0/en/YieldMax-Launches-Semiconductor-Portfolio-Option-Income-ETF-CHPY.html">fund </a>can switch to employing options on semiconductor companies or ETFs when liquidity in individual stock options is minimal or cost of trading is excessive.
Also Read: <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/04/44698920/as-trump-tariffs-spark-panic-investors-rush-into-these-5-recession-proof-etfs">As Trump Tariffs Spark Panic, Investors Rush Into These 5 &#8216;Recession-Proof&#8217; ETFs</a>
Why It Matters: In contrast to conventional equity ETFs, CHPY seeks to provide weekly income distributions. 
The first payment is due April 16.
The income comes not only from option premiums but also from dividends on underlying positions and interest on short-term U.S. Treasuries that serve as collateral.
YieldMax indicates that investment choices are based on considerations such as liquidity, volatility of stocks, and price—considerations that both affect stock selection and options positioning.
Although the semiconductor industry has experienced high growth and volatility, CHPY&#8217;s approach seems geared to attract income-seeking investors in a high-momentum segment of the market without being dependent on capital appreciation alone.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44695765/crypto-etfs-sink-as-trump-tariffs-trigger-panic-this-could-reset-the-macro-narrative">Trump Tariffs Spark $800M Crypto ETF Rout: Can The Macro Narrative Shift?</a></li>
</ul>
Image: Shutterstock

New ETFs

Tech

AVGO

CHPY

NVDA

QCOM

YieldMax's New ETF Taps Into Semiconductor Power With Weekly Income Promise

Blink Charging Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLNK#NASDAQ">BLNK</a>) ("Blink" or the "Company"), a leading global owner, operator, provider, and manufacturer of electric vehicle (EV) charging equipment and services, announced today it has filed its Form 10-K for the year ended December 31,2024 with the Securities and Exchange Commission (SEC).
The Company noted that today's Form 10-K filing reflects no change to the 2024 financial results as reported in the Company's fourth quarter and full year 2024 press release, earnings call and investor deck issued on March 13, 2025. There were no restatements of previously filed financial statements.
With Blink's filing of its Form 10-K for the year ended December 31, 2024, the Company expects to regain compliance with NASDAQ in the near future.

BLNK

Blink Charging Co. Announces Filing Of Form 10-K For 2024; With Filing Of Form 10-K For Year Ended Dec 31, 2024, Expects To Regain Compliance With Nasdaq In Near Future

AAOI

ADTN

ANET

AUDC

AVNW

CALX

CIEN

COMM

CSCO

ERIC

EXTR

FFIV

GILT

HIVE

HLIT

MOBBW

NTCT

NTGR

RBBN

VIAV

VSAT

Shares of communication equipment stocks are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

Wells Fargo analyst Ken Gawrelski maintains Roblox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) with a Overweight and lowers the price target from $76 to $70.

RBLX

Wells Fargo Maintains Overweight on Roblox, Lowers Price Target to $70

ATRO

AVAV

AXON

BWXT

BYRN

CDRE

Embraer-Empresa Brasileira De Aeronautica

ESLT

EVEX

EVTL

MRCY

SARO

SATL

SPAI

SPCE

Shares of aerospace and defense companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

AGCO

ALSN

ASTE

ATMU

BLBD

CVGI

EPAC

ESAB

FELE

FSTR

GTES

GTLS

HLIO

LECO

LXFR

MIDD

OTIS

PCAR

PDYN

PRLB

RAIL

SPXC

TWIN

UGRO

WPRT

Shares of machinery companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

Macro Economic Events

Economics

Federal Reserve

Fed Minutes: A Few Participants Cautioned An Abrupt Repricing Of Risk In Financial Markets Could Exacerbate Effects Of Any Negative Economic Shocks; Fed Staff Projection For Real GDP Growth Was Weaker Than One Prepared For The January Meeting

Wells Fargo analyst Michael Sison maintains RPM Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>) with a Overweight and lowers the price target from $140 to $116.

Wells Fargo Maintains Overweight on RPM Intl, Lowers Price Target to $116

Fed Minutes: Some Participants Observed FOMC May Face Difficult Trade-offs If Inflation Proved More Persistent While The Outlook For Growth And Employment Weakened; Several Participants Emphasized That Elevated Inflation Could Prove To Be More Persistent Than Expected; Almost All Participants Supported Slowing Pace Of Balance Sheet Runoff; Several Did Not See A Compelling Case For A Slower Runoff Pace

Fed Minutes: Participants Remarked That Uncertainty About Net Effect Of Government Policies On The Outlook Was High, Making It Appropriate To Take A Cautious Approach; A Majority Of Participants Noted Potential For Inflationary Effects From Various Factors To Be More Persistent Than They Projected; Participants Assessed FOMC Was Well-positioned To Wait For More Clarity On The Outlook; Almost All Participants Viewed Risks To Inflation As Tilted To The Upside, Risks To Employment As Tilted To The Downside

All Participants At Fed's March 18-19 Meeting Viewed It Appropriate To Keep Interest Rates Unchanged In Light Of Elevated Uncertainty Around Economic Outlook, Minutes Show

In the preceding three months, 5 analysts have released ratings for Allstate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>), presenting a wide array of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Allstate, presenting an average target of $224.0, a high estimate of $243.00, and a low estimate of $187.00. Marking an increase of 0.63%, the current average surpasses the previous average price target of $222.60. 
<img src="https://www.benzinga.com/files/images/story/2025/1744221687_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Allstate. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;-----------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Meyer Shields &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers &#x7C;Outperform &#x7C; $228.00&#x7C;$240.00 &#x7C; 
&#x7C;Jimmy Bhullar &#x7C;JP Morgan &#x7C;Raises &#x7C;Overweight &#x7C; $222.00&#x7C;$217.00 &#x7C; 
&#x7C;Meyer Shields &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Raises &#x7C;Outperform &#x7C; $240.00&#x7C;$235.00 &#x7C; 
&#x7C;Elyse Greenspan &#x7C;Wells Fargo &#x7C;Raises &#x7C;Equal-Weight &#x7C; $187.00&#x7C;$186.00 &#x7C; 
&#x7C;Meyer Shields &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Raises &#x7C;Outperform &#x7C; $243.00&#x7C;$235.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Allstate. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Allstate compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Allstate's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Allstate's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/ALL/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Allstate analyst ratings.</a>
<h2>Delving into Allstate's Background</h2>
Allstate is one of the largest US property-casualty insurers in the US. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 6,000 exclusive agents.
<h3>Understanding the Numbers: Allstate's Finances</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Allstate displayed positive results in 3M. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 11.28%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Allstate's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 11.51%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Allstate's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 9.91% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Allstate's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.69% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 0.42, caution is advised due to increased financial risk.
<h2>How Are Analyst Ratings Determined?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Allstate Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

Wells Fargo analyst Derek Archila maintains Nurix Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRIX#NASDAQ">NRIX</a>) with a Overweight and lowers the price target from $32 to $25.

NRIX

Wells Fargo Maintains Overweight on Nurix Therapeutics, Lowers Price Target to $25

MYR Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYRG#NASDAQ">MYRG</a>) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated MYR Group and provided 12-month price targets. The average target is $137.5, accompanied by a high estimate of $159.00 and a low estimate of $124.00. This current average represents a 23.18% decrease from the previous average price target of $179.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1744221677_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The analysis of recent analyst actions sheds light on the perception of MYR Group by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Brian Brophy &#x7C;Stifel &#x7C;Lowers &#x7C;Buy &#x7C; $131.00&#x7C;$157.00 &#x7C; 
&#x7C;Kashy Harrison &#x7C;Piper Sandler &#x7C;Announces &#x7C;Neutral &#x7C; $124.00&#x7C;- &#x7C; 
&#x7C;Sangita Jain &#x7C;Keybanc &#x7C;Announces &#x7C;Overweight &#x7C; $136.00&#x7C;- &#x7C; 
&#x7C;Justin Hauke &#x7C;Baird &#x7C;Lowers &#x7C;Outperform &#x7C; $159.00&#x7C;$201.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to MYR Group. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of MYR Group compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of MYR Group's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of MYR Group's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MYRG/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on MYR Group analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>About MYR Group</h2>
MYR Group Inc is a U.S.-based holding company that provides specialty electrical construction services through its subsidiaries. The company operates through two segments. The transmission and distribution segment provides designing, engineering, procurement, construction, upgrade, maintenance, and repair services on transmission and distribution networks and substation facilities. The commercial and industrial segment provides services such as the design, installation, maintenance, and repair of commercial and industrial wiring, installation of traffic networks, and the installation of bridges. MYR Group generates the majority of its sales from the United States and Canada.
<h3>Breaking Down MYR Group's Financial Performance</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Decline in Revenue: Over the 3M period, MYR Group faced challenges, resulting in a decline of approximately -17.37% in revenue growth as of 31 December, 2024. This signifies a reduction in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: MYR Group's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 1.92%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): MYR Group's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 2.68%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): MYR Group's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 1.01%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: MYR Group's debt-to-equity ratio is below the industry average. With a ratio of 0.2, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MYRG

Analyst Expectations For MYR Group's Future

ABEV

ANDE

BRBR

BRFS

CART

CASY

CELH

CENT

CENTA

COCO

COKE

COST

COTY

FIZZ

Fomento Economico Mexicano S.A.B. De C.V.

FRPT

HFFG

HNST

IPAR

ISPR

MDLZ

MGPI

MNST

PFGC

PSMT

SNYR

TBBB

UNFI

UPXI

USFD

USNA

WALD

WEST

Shares of consumer staple companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

Press Releases

General

NewGen Launches Innovative Lifetime Egg Freezing Service to Address Growing Market Need in Asia

Health Care

NewGen Announces Strategic Acquisition of MicroSort Reproductive Technology

NewGen Announces Reverse Stock Split

Management

NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director

NewGen Issues Clarification on Press Release Titled "NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director" dated February 20, 2025

NewGen Regains Compliance with Nasdaq Minimum Bid Price Requirement and Announces Listing Transfer to the Nasdaq Capital Market

NewGen and BOBCARE Announce Strategic Collaboration to Expand Fertility Services in Kyrgyzstan

NewGenIvf Provides Update on Proposed Reverse Merger with European Wellness Holdings and Completion of Strategic Acquisition of MicroSort Reproductive Technology

NewGenIVF Announces Termination of Proposed Reverse Merger Transaction with European Wellness

Financing

NewGen Secures Strategic Funding to Drive International Expansion and Corporate Growth

NIVF

American Shared Hospital Services Common Stock

American Shared Hospital

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International

Enzo Biochem, Inc. Common Stock ($0.01 Par Value)

Enzo Biochem

Kindly MD

Mobile-health Network Solutions - Class A Ordinary Shares

Mobile-health Network

ModivCare

MSP Recovery, Inc. - Class A Common Stock

MSP Recovery

NewGenIvf Group

Ontrak

P3 Health Partners Inc. - Class A Common Stock

P3 Health Partners

Precipio

Syra Health

Vivos Therapeutics

Screenshot 2025-03-05 at 6.43.43 PM

NewGenIvf Taps Veteran Healthcare Executive To Build Out Its New Egg Freezing Service

Screenshot 2025-02-24 at 6.31.24 PM

Biotech

NewGenIvf Inks $5 Million Deal To Buy Sperm-Sorting Technology Company MicroSort, Eyes China Expansion

The Search Is Over: NewGenIVF Inks Reverse Merger Agreement With European Wellness Investment Holdings

Comments

NewGenIvf Group

Vendite allo scoperto

NewGenIvf Group (NASDAQ:NIVF) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO